BridgeBio Pharma
BBIO
#2244
Rank
HK$52.75 B
Marketcap
HK$279.12
Share price
-0.67%
Change (1 day)
-6.14%
Change (1 year)

Market capitalization of BridgeBio Pharma (BBIO)

Market cap: HK$52.75 Billion

As of January 2025 BridgeBio Pharma has a market cap of HK$52.75 Billion. This makes BridgeBio Pharma the world's 2244th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BridgeBio Pharma from 2019 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$52.75 B28.45%
2024HK$41.06 B-25.13%
2023HK$54.85 B516.31%
2022HK$8.89 B-53.51%
2021HK$19.14 B-71.7%
2020HK$67.64 B100.39%
2019HK$33.75 B

End of Day market cap according to different sources

On Jan 22nd, 2025 the market cap of BridgeBio Pharma was reported to be:

HK$52.75 Billion
by Nasdaq info icon info icon
HK$52.75 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HK$0.16 B-99.69%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$7.70 B-85.40%๐Ÿ‡บ๐Ÿ‡ธ USA